USA VC Funds

Oxy Capital is a Lisbon-based private equity firm with a strong focus on supporting small and medium-sized enterprises (SMEs) through tailored investment strategies. Since its founding in 2011, Oxy Capital has concentrated on restructuring, private equity, mezzanine debt, and special situations. With over 25 professionals across offices in Lisbon and Milan, the firm manages a variety of funds, including the Fundo de Reestruturação Empresarial and Oxy Capital Mezzanine Fund, which emphasize economic revitalization and sustainable growth. Oxy Capital specializes in creative financing solutions, particularly for businesses facing operational challenges or in need of restructuring. Its investment philosophy is driven by flexibility and boldness, enabling the firm to venture into under-explored markets and deliver high returns for investors. The firm’s portfolio spans industries like manufacturing, energy services, and commercial products, with a clear focus on fostering competitiveness in its portfolio companies. Led by Managing Partner Miguel Lucas, the team prides itself on its hands-on approach, working closely with businesses to enhance value while offering deep market insights. Oxy Capital’s dual presence in Portugal and Italy gives it a strong foothold in Southern Europe, making it a key player in revitalizing SMEs across the region.

Oyster Ventures, founded in 2016 and headquartered in San Francisco, is a venture capital firm that targets early-stage investments in frontier technology companies. The firm aims to drive innovation by investing in startups that bring liquidity and efficiency to traditional industries, support globalization, and have significant scaling potential. Notable companies in their portfolio include Ridepanda, Rithmm, and Advance, reflecting their diverse investment interests in specialty retail, business productivity software, and financial software. Key exits like Postmates and Clearbit highlight their success. Led by Sophie Liao and Ran Wang, Oyster Ventures is known for its hands-on approach and strategic support, helping portfolio companies navigate the complexities of growth and scale. The firm is particularly interested in technologies that can disrupt and modernize outdated systems, making industries more efficient and globally accessible. Their investment strategy focuses on identifying and nurturing startups with the potential to become market leaders through innovative solutions and robust business models. This approach has positioned Oyster Ventures as a significant player in the venture capital landscape, dedicated to fostering technological advancements and supporting visionary entrepreneurs.

Pacific 8 Ventures is a Taiwan-based venture capital firm, primarily focusing on healthcare and disruptive technology platforms. Founded by Jack Liang, the firm targets early-stage companies, with a preference for being the first institutional investor. Pacific 8 Ventures invests in transformative technologies, especially those reshaping therapeutics, diagnostics, and broader health services. Their investment approach is global, with a strong emphasis on the U.S. market, where disruptive healthcare innovations are burgeoning​. Pacific 8 Ventures has built a diverse portfolio of companies at the forefront of healthcare innovation. Notable investments include Mammoth Biosciences, known for its pioneering work with CRISPR technology, and BillionToOne, which revolutionizes prenatal testing. They have also invested in companies like Fauna Bio, which uses mammalian genetic data for novel therapeutics, and Dorian Therapeutics, focused on anti-aging technologies. The firm is also involved in significant collaborations, such as Mammoth Biosciences' $1 billion partnership with Bayer. Pacific 8 Ventures is dedicated to helping companies navigate the challenges of scaling in the competitive healthcare landscape, leveraging deep expertise and strategic support to drive success.

Paladin Capital Group is a global venture capital firm based in Washington, D.C., with additional offices in New York, Silicon Valley, London, and Luxembourg. Since its inception in 2001, Paladin has managed over $1 billion in committed capital, investing in more than 65 companies across North America, Europe, Australia, and South America. The firm focuses on innovative technology, particularly in cybersecurity, which has become a primary area of expertise. Notable investments include Corellium, which specializes in mobile and IoT virtualization; Digital Shadows, a provider of cyber situational awareness; and Expel, a company offering transparent managed security. Other significant portfolio companies include RangeForce, which offers a cyber simulation and skills analytics platform, and Hack The Box, an online cybersecurity training platform. Paladin Capital Group employs a dual-use investment approach, leveraging its knowledge of both commercial and government markets to provide unique insights and opportunities for its portfolio companies. This strategy helps startups develop strategic partnerships, access new markets, and navigate financing options. The firm is committed to adding value beyond capital by supporting portfolio companies with strategic guidance and leveraging its extensive network to maximize returns. Paladin has been actively involved in numerous successful exits, including the sale of Hubble Technologies to KKR-backed NetSPI.

Pallasite Ventures is a venture capital firm that focuses on providing early-stage financing to high-growth companies across a variety of industries, including tech and consumer products. Founded in 2012 and based in Vancouver, Canada, Pallasite Ventures aims to fund companies whose leaders have the vision and skill to transform their markets. The firm is particularly active in Seed and Series A deals, offering investments ranging from $100,000 to $1.5 million USD and maintaining significant reserves to support their portfolio companies as they grow. The firm has invested in over 60 companies, including notable names like Dooly, Prescryptive, and CalypsoAI. Pallasite Ventures places a strong emphasis on adding value and providing support to its portfolio companies, ensuring they have the resources and freedom needed for long-term growth. The firm's investment focus spans multiple regions, including Vancouver, San Francisco, Boston, Denver, Chicago, and Toronto. Pallasite Ventures is led by Managing Partner Christopher Bissonnette, Ph.D., and operates with an agile and supportive approach, aiming to streamline decisions and provide strategic advice to its investments​.

Palm Drive Capital, headquartered in New York City with additional offices in San Francisco and Taipei, is a venture capital firm that specializes in early-stage investments. Founded in 2014, the firm primarily backs Seed and Series A tech founders across SaaS, AI, fintech, and e-commerce sectors. Their global approach underscores their belief that "innovators are everywhere," supporting startups from diverse geographical regions​. The firm has a notable portfolio, including investments in Deep Instinct, a leader in cybersecurity, and MoneyLion, a modern challenger bank. Palm Drive Capital has also achieved significant exits, such as those from Clover Health and Long Game, highlighting their success in identifying and nurturing high-potential startups​. Palm Drive Capital prefers a collaborative investment approach, frequently co-investing with other venture firms rather than leading rounds. Their strategy focuses on scalable solutions in high-growth markets, providing not only financial support but also strategic guidance through their extensive network. This approach has positioned them as a valuable partner for early-stage companies looking to scale efficiently. Led by co-founders Hendrick Lee and Seamon Chan, the team comprises experts like Catherine Cai and Nick Hsu, who contribute significant investment and operational expertise. For startups aiming to engage with Palm Drive Capital, demonstrating a robust product-market fit and a clear scalability plan is crucial. The firm values well-prepared pitches that highlight market opportunities and strategic growth plans​.

Panacea Venture is a global healthcare-focused venture capital fund with a strong track record in early-stage life sciences investments. Spun out of Kleiner Perkins, Panacea specializes in building innovative companies that target unmet medical needs, particularly in biotech, therapeutics, and medical devices. Their investment scope spans cell and gene therapies, diagnostics, and emerging technologies like AI-driven healthcare solutions. With a global reach, Panacea has offices in Shanghai, Boston, and Silicon Valley, leveraging its cross-border expertise to tap into transformative healthcare innovations across North America and Asia. The firm is highly active, leading early-stage rounds and often taking board seats, while its venture operator model allows them to incubate and actively manage portfolio companies. Notable portfolio names include groundbreaking companies in immunotherapy and gene editing, such as TriArm Therapeutics and Kindstar Global. Panacea’s investment approach focuses on deep due diligence and long-term partnerships. They seek companies with strong scientific foundations and scalable technologies, preferring founders with deep domain expertise. The fund’s managing partner, James Huang, along with a diverse team of venture partners, brings over 100 years of combined experience in both venture capital and life sciences industries. They continue to focus on early-stage growth, with an emphasis on hands-on involvement to drive value from inception to public market success.

Panache Ventures is a leading Canadian venture capital firm specializing in early-stage investments, particularly at the pre-seed and seed stages. Founded in 2018, the firm has a strong national presence with offices in Vancouver, Calgary, Toronto, and Montreal. Panache Ventures focuses on supporting ambitious entrepreneurs across various sectors, including enterprise software, AI/ML, fintech, blockchain/web3, health tech, and climate tech. Panache Ventures' first fund raised over $58 million and invested in 100 companies, achieving notable exits such as fintech company Flinks and proptech company Lane. Their second fund, Panache Ventures II, closed at $100 million, with significant investments from Alberta Enterprise Corporation, Ontario Capital Growth Corporation, Investissement Québec, BMO Financial Group, and TELUS Ventures. This fund aims to double down on pre-seed and seed investments in Canadian technology startups, supporting around 20 new investments per year​. The firm is known for its commitment to diversity and inclusion, with 52% of its portfolio companies being led by persons of color and a rate of investment in women-led startups that is 1.8 times the national average for Canadian venture capital​​. Panache Ventures emphasizes a founder-friendly approach, providing extensive mentorship and support throughout the growth of their portfolio companies. Key team members include Chris Neumann, Scott Loong, Prashant Matta, and Patrick Lor, who collectively bring a wealth of experience and expertise to the firm.

Panakès Partners, based in Milan, is a leading venture capital firm specializing in life sciences. Founded by Diana Saraceni, who has over 20 years of experience in the VC industry, the firm focuses on early-stage startups and SMEs developing innovative technologies in biotech, diagnostics, and medical devices. Their portfolio includes notable investments like EndoStart and Diadem, reflecting their commitment to groundbreaking solutions in healthcare. Panakès primarily targets Europe and Israel, aiming to address significant unmet medical needs with a robust ESG framework. Their latest €175 million fund, the Purple Fund, emphasizes Series A investments, supporting around 15-18 companies with average checks ranging from €5 to €10 million. Known for leading rounds, Panakès actively engages with startups through a rigorous selection process, valuing sustainability and impactful health solutions. The team, led by Saraceni, brings extensive expertise and a strong network in the life sciences sector, bolstered by their participation in various national and international advisory boards. For entrepreneurs, Panakès is approachable via direct submissions to their email, fostering a transparent and accessible investment process.

Pangaea Ventures is a leading venture capital firm specializing in hard tech and impact investments. Focused on leveraging advancements in materials science, chemistry, and biology, Pangaea Ventures invests in startups addressing global challenges like climate change, food security, and human health. Their portfolio includes innovative companies such as CarbonCure, Aspect Biosystems, and NewLeaf Symbiotics, which are pioneering solutions in carbon sequestration, bioprinted tissues, and sustainable agriculture, respectively. With a geographic focus on North America, Pangaea Ventures typically invests in early to growth-stage companies. Their investment strategy centers around creating measurable impact, often leading investment rounds with significant capital. They are particularly interested in startups that can demonstrate clear, scalable solutions to critical environmental and health problems. Pangaea Ventures' team, based in Vancouver, Scottsdale, and Hillsborough, includes experts like General Partner Chris Erickson, who bring extensive experience in science and business. The firm is known for its rigorous due diligence process and close collaboration with portfolio companies to maximize both financial and impact returns. Startups are encouraged to approach Pangaea with detailed proposals that highlight innovative, market-ready technologies. In summary, Pangaea Ventures is a key player in the venture capital landscape, driving sustainable innovation through strategic investments in transformative technologies.

Panoramic Ventures, also known as BIP Ventures, is a venture capital firm that invests in early-stage and growth-stage technology companies. With a strong focus on supporting the innovation economy, Panoramic Ventures partners with entrepreneurs to build impactful businesses across diverse industries. Founded as BIP Capital, the firm has a robust portfolio and offers comprehensive private market investment solutions. Their investment strategy is centered around identifying high-potential startups and providing them with the necessary capital and strategic guidance to scale successfully. Panoramic Ventures has a notable portfolio of companies, including OncoLens, which specializes in oncology management solutions, and Acclivity Health Solutions, which focuses on improving end-of-life care through advanced technology platforms.

Pantera Capital is a pioneering venture capital firm focused exclusively on blockchain and cryptocurrency investments. Founded by Dan Morehead in 2003, Pantera launched the first cryptocurrency fund in the U.S. in 2013 when Bitcoin was valued at $65 per BTC. They have since introduced various funds, including the first blockchain-focused venture fund and the first early-stage token fund in 2017. Pantera manages $5.6 billion in assets, providing investors with comprehensive exposure to the blockchain ecosystem through venture equity, early-stage tokens, and liquid tokens. Their investment strategy is global, having backed over 100 blockchain companies and 110 early-stage token deals across sectors like decentralized finance (DeFi), next-gen payment systems, and institutional trading tools. The firm's notable funds include the Pantera Venture Funds, Pantera Bitcoin Fund, Pantera Liquid Token Fund, and the all-encompassing Pantera Blockchain Fund. Their extensive portfolio features key players in the blockchain space, contributing significantly to the industry's infrastructure and growth. Pantera Capital operates from offices in the Bay Area, New York, and Puerto Rico, with a team of seasoned professionals bringing decades of experience from top-tier financial firms and technical backgrounds.

Pappas Capital is a prominent venture capital firm based in Durham, North Carolina, specializing in investing in next-generation life science, agriculture, and technology companies. Established in 1994 by Art Pappas, the firm has a robust track record of investing in over 90 companies across the United States, Canada, and Asia. Their investments focus on innovative solutions that address significant unmet medical needs and span a wide range of diseases, including cancer and hemophilia​. Pappas Capital operates through three primary divisions: Pappas Ventures, Specialized Fund Management, and Translational Medicine. Pappas Ventures is their flagship arm, dedicated to life science investments, particularly in undercapitalized markets. Specialized Fund Management creates and manages custom investment vehicles, while Translational Medicine partners with academic institutions to accelerate the development of scientific discoveries. The firm boasts a seasoned team of investment professionals, including Art Pappas, Elizabeth Kelly, and Barry Myers, who bring extensive experience in pharmaceuticals, biotechnology, and venture capital. This expertise enables Pappas Capital to provide valuable insights and strategic guidance to their portfolio companies, helping them navigate the complexities of drug development and commercialization. Pappas Capital has successfully guided numerous companies to significant exits, including IPOs and acquisitions. Recent investments include companies like VFlow Tech and Enlaza Therapeutics, further emphasizing their commitment to advancing groundbreaking life science technologies​.

Parade Ventures is a venture capital firm focused on pre-seed and seed-stage investments, primarily in enterprise technology companies. Founded by Shawn Merani in 2018, the firm is headquartered in Los Gatos, California. Parade Ventures targets businesses with recurring revenue models, strong capital efficiency, and scalable operations. They lead or co-lead early-stage funding rounds, often being the first institutional money into a company. Shawn Merani, with extensive experience in early-stage investing and entrepreneurship, has backed successful companies like Dollar Shave Club, Moveworks, and Trusted Health. He was also a founding partner of Liquidnet’s Private Shares marketplace, showcasing his deep expertise in tech and private market investments. Parade Ventures' investment thesis revolves around identifying companies with high margins, lifetime value, and repeatable sales models. The firm emphasizes capital-efficient businesses that can scale sustainably, and it provides portfolio companies with unparalleled access to a network of top-tier founders and operators for mentorship and support. Notable investments include companies such as Plastiq and Clubhouse, reflecting Parade Ventures' focus on cutting-edge technology and scalable solutions in industries like software, financial services, and productivity tools. Parade Ventures continues to be a key player in helping early-stage tech companies navigate their growth journeys.

Paradigm Ventures is a prominent venture capital firm that excels in investing within the cryptocurrency and blockchain technology sectors. Their portfolio boasts notable investments such as Coinbase, Chainalysis, and OpenSea, reflecting their strong presence in the digital assets space. They focus on investing in early-stage ventures but also support companies through various growth stages with investment sizes ranging from $1M to $100M. Paradigm's investment strategy is deeply research-driven, often leading rounds and providing significant hands-on support in areas like technical mechanism design, smart contract security, and operational scaling. This approach not only ensures the technological robustness of their portfolio companies but also aids in achieving long-term growth and market leadership. Geographically, Paradigm is heavily invested in the United States, particularly within major tech hubs such as San Francisco. However, their investments and interest span globally, targeting innovative companies that push the boundaries of blockchain technology. Paradigm prefers to be approached by startups with a clear and compelling vision for their technology and its impact on the crypto ecosystem. They are highly selective, looking for teams with strong technical foundations and a demonstrated ability to execute their vision effectively.

Pareto Holdings, founded by Edward Lando and Jon Oringer in 2020, is a Miami-based venture capital firm specializing in early-stage investments. The fund has a dynamic portfolio that includes notable companies such as Burnbot, nsave, and Elevated Signals, reflecting its focus on Environmental Services (B2B), Financial Software, and Business/Productivity Software industries. Pareto Holdings primarily targets startups with high potential for globalization, emphasizing early growth companies with significant momentum. Geographically, the firm maintains a strong presence in the U.S., with a particular focus on the Miami entrepreneurial ecosystem. The investment strategy at Pareto Holdings involves being one of the first backers of exceptional entrepreneurs. They typically lead funding rounds and are known for their active involvement in their investments. The average check size varies, but they maintain a hands-on approach, often participating in the operational aspects of the startups they invest in. Approaching Pareto Holdings requires demonstrating high growth potential and a clear path to global expansion. They value innovation and market disruption, looking for teams that can leverage their extensive network and resources effectively. The leadership team at Pareto Holdings includes Edward Lando, Jon Oringer, Rohit Bhadange, Annie Wasserman, and Benjamin-Jean Cambier, all based in Miami. This diverse team brings a wealth of experience in venture capital and business development, ensuring robust support for their portfolio companies.

Pathbreaker Ventures, established in 2016 and based in San Francisco, focuses on early-stage investments in startups tackling significant global challenges with innovative hardware and software solutions. Led by Ryan Gembala, the firm supports specialized engineering and product leaders, often investing when a company is still in its foundational stage. Pathbreaker invests in sectors like AI, robotics, and deep tech, targeting problems valued at over $100 billion​. Ryan Gembala, the Founder and Managing Partner, has a rich background in venture capital and corporate development, having previously worked at Facebook and Azure Capital. His experience spans the full startup lifecycle, from founding and operating companies to investing and acquiring venture-backed firms​. Pathbreaker Ventures' portfolio includes companies like Spiketrap, an AI for real-time language understanding, and Mux, which builds video streaming and analytics APIs. The firm co-invests with top-tier venture firms and is known for its hands-on approach, providing capital, strategic advice, and access to a vast network of industry experts.

PBM Capital, founded by entrepreneur Paul Manning in 2010, is a dynamic healthcare-focused investment firm with a strong emphasis on pharmaceuticals, biotechnology, and life sciences. Headquartered in Charlottesville, Virginia, with an additional office in New York, PBM partners with scientists and innovators to create groundbreaking therapies that significantly improve patient outcomes. Their team provides capital along with critical operational and strategic expertise, helping companies navigate complex healthcare markets and scale rapidly. PBM’s portfolio boasts several notable successes, including AveXis, which was acquired by Novartis for $8.7 billion, and Dova Pharmaceuticals, which completed an IPO before being acquired by Swedish Orphan Biovitrum. The firm seeks out companies with revolutionary science and strong leadership, focusing on areas such as gene therapy, biologics, and drug development. PBM takes an active role in guiding its investments, offering not only funding but also leveraging its extensive network to accelerate commercialization. Their investment strategy centers around long-term value creation, seeking out companies with life-changing technologies and the potential to transform healthcare. By combining operational experience with capital investment, PBM aims to help founders bring revolutionary therapies to market and create lasting impact​.

Peak State Ventures, founded in 2017 and based in New York City, is a venture capital firm that focuses on investing in the future of work, PropTech, and digital healthcare. The firm supports early-stage companies and aims to back visionary founders who are transforming industries through technology. Peak State Ventures invests in seed and early-stage companies, providing both capital and strategic guidance. The firm has a diverse portfolio that includes notable companies like Snapdocs, Turing, and Mighty Buildings. Snapdocs is a leader in real estate transaction automation, while Turing democratizes the labor market by connecting U.S. companies with remote software engineers from around the world. Mighty Buildings focuses on 3D printing and sustainable construction technologies. Other portfolio companies include Feather, Brilliant, Raise, Stensul, and Ironclad. Peak State Ventures is led by a team of experienced entrepreneurs and investors. Key members include Jason Freedman, Bryan Ciambella, Omri Barzilay, Rajit Malhotra, and Seva Zakharov. They bring extensive experience in startup operations, investment, and strategic development, helping portfolio companies navigate growth challenges and achieve their business objectives.

PeakBridge VC is a venture capital firm focused on Agri-FoodTech, investing in companies that address major challenges in the global food system. Founded in 2016 and headquartered in Malta, PeakBridge aims to create long-term impact by investing in startups that drive sustainable solutions, improving both environmental and health outcomes across the food chain. The firm’s investment strategy is centered on five key areas: ingredient innovations, alternative protein technologies, food system digitalization, nutrition & health, and alternative farming systems. By investing in these sectors, PeakBridge helps startups scale solutions that tackle issues such as food waste, nutrition deficiencies, and the carbon footprint of food production. Its portfolio includes innovative companies like Standing Ovation (dairy substitutes through microbial fermentation), Vow (cultured meat), and Rival Foods (plant-based protein). PeakBridge operates through its FoodSparks® Seed Fund for early-stage European and Israeli startups, and Growth II Fund for Series A-B investments in Europe, the U.S., and Israel. The firm’s total assets under management exceed $250 million, with significant backing from Edmond de Rothschild Private Equity. As an Article 9 fund under the Sustainable Finance Disclosure Regulation (SFDR), PeakBridge integrates strict ESG principles into its investments, ensuring all portfolio companies contribute to a healthier and more sustainable food system.

Pear VC is a venture capital firm that specializes in pre-seed and seed investments, focusing on partnering with founders at the earliest stages to help turn great ideas into category-defining companies. Founded in 2013 by Pejman Nozad and Mar Hershenson, Pear VC has backed over 150 companies, including notable successes like DoorDash, Guardant Health, Gusto, and Aurora Solar. The firm’s investment philosophy emphasizes a hands-on approach, providing extensive support in areas such as product-market fit, go-to-market strategies, recruiting, and fundraising. Their check sizes range from $250K to $5M for pre-seed and seed investments, with follow-on investments of up to $10M. Pear VC's focus areas include consumer tech, SaaS, enterprise tech, healthcare, deep tech, fintech, biotech, climate tech, and AI. Pear VC’s team consists of experienced founders and industry experts who bring deep operational knowledge to support portfolio companies. They run PearX, an early-stage bootcamp for high-potential founders, helping them build scalable ventures from the ground up.

Pebblebed is an early-stage venture capital firm founded in 2022, based in San Francisco, California. The firm focuses on investing in technology companies that demonstrate profound technical insight and have the potential to build long-term competitive advantages. Pebblebed targets investments in companies that create significant value through innovation, aiming to support startups that are capable of developing strong market positions and enduring customer relationships. Pebblebed is particularly interested in businesses that can establish deep end-user stickiness, build strong brand loyalty, or create high switching costs for customers, thereby ensuring sustainable growth and market leadership. The firm’s investment strategy is characterized by its emphasis on deep technical knowledge, leveraging the expertise of its partners who have extensive backgrounds in engineering and technology. The firm has made several investments across various sectors, including AI, computing infrastructure, and other tech-driven industries. Pebblebed’s approach is to provide more than just capital; it aims to be a strategic partner to its portfolio companies, offering guidance and resources to help them scale and succeed in competitive markets.

Pegasus Tech Ventures, based in Silicon Valley, is a global venture capital firm managing over $2 billion in assets. Founded in 2011, Pegasus offers a unique Venture Capital-as-a-Service (VCaaS) model, partnering with large corporations to invest in emerging tech startups. This involves vetting investment opportunities, managing investments, and connecting startups to a network of over 30 international corporate partners to accelerate growth. Notable investments include high-profile companies such as SpaceX, Twitter, Airbnb, SoFi, DoorDash, and 23andMe. Pegasus' diverse portfolio spans sectors like consumer electronics, automotive, healthcare, AI, and fintech, reflecting its broad investment strategy. Recently, Pegasus launched a $100 million fund with Denka Company Limited, focusing on ICT, energy, healthcare, and sustainable living. This fund aims to invest in startups across the US, Europe, Israel, and Asia, enhancing Denka's growth and innovation efforts. Additionally, Pegasus founded and sponsors the Startup World Cup, one of the largest startup competitions globally, with a $1 million investment prize. This competition supports regional innovation ecosystems worldwide and connects them to Silicon Valley. Led by founder and CEO Anis Uzzaman, Pegasus leverages its extensive global network and deep tech expertise to drive corporate innovation and help emerging tech companies achieve industry leadership.

Pelion Venture Partners, based in Salt Lake City, Utah, is a prominent venture capital firm that has been active since 1986. The firm focuses on early-stage investments in technology sectors, including enterprise software, digital media, SaaS, and cloud services. Pelion has made over 300 investments, with notable exits such as Cloudflare, Domo, and Venafi. Their investment strategy involves supporting startups with innovative solutions and strong growth potential. Pelion typically invests in seed and Series A rounds, providing the necessary capital and strategic support to help companies scale. Recent investments include companies like Jump and Cartwheel​.

Perot Jain is a Dallas-based early-stage venture capital firm co-founded by Ross Perot Jr. and Anurag Jain in 2014. The firm primarily focuses on investing in innovative and disruptive startups within the healthcare, mobility, business services, and tech-enabled B2B sectors. Notable investments include companies like Access Healthcare, specializing in healthcare IT solutions, and Worlds, which creates AI-generated models for business process optimization. Other significant portfolio companies are Spacee, which offers virtual store walkthroughs, and Booster, a mobile fuel delivery service. Perot Jain typically invests up to $500,000 in seed and Series A rounds, aiming to support scalable businesses located in the United States. The firm leverages its extensive network and operational expertise to provide more than just capital, offering strategic guidance and resources to help startups achieve transformational growth. The team at Perot Jain includes a mix of founders, executives, and industry experts who work closely with entrepreneurs to drive innovation and impact. The firm has made over 70 investments and maintains a strong presence in the North Texas startup ecosystem, contributing to the region's growth as a national center for technology and innovation.

Peterson Ventures is a seed-stage venture capital firm that helps entrepreneurs build successful businesses from the ground up. Headquartered in Utah with an additional office in the Bay Area, Peterson Ventures focuses on SaaS, digital commerce, fintech, and healthtech sectors. The firm typically invests $250K to $1M in early-stage startups, aiming to bridge the gap between angel investors and traditional venture capital. Founded in 2008 as part of the Peterson Partners platform, Peterson Ventures has invested in over 200 companies, including notable names like Allbirds, Ethos, Lucid Software, and HireVue. The firm recently raised $140 million for its fourth fund and its first opportunity fund, allowing continued investment in their best-performing portfolio companies as they scale. The firm is led by Managing Director Ben Capell, with a team of experienced partners and associates who bring diverse backgrounds in entrepreneurship, investment banking, and corporate strategy. Peterson Ventures is known for its founder-first approach, providing not just capital but also strategic guidance and support to help startups overcome challenges and achieve growth.

Petri Bio is a biotechnology company focused on developing next-generation therapeutics derived from gut microbes. The company leverages the vast genetic information within the microbiome to discover and develop novel treatments for challenging diseases such as inflammatory bowel disease (IBD) and fatty liver disease. These diseases often have limited effective treatments, making Petri Bio's work particularly impactful. Founded by Shu Li, a Ph.D. in plant biology, and Joseph Schinaman, a biomedical researcher, Petri Bio is committed to using microbial compounds to create new medicines. Their approach involves mining microbial genomes for peptides with therapeutic potential, which they believe could lead to breakthroughs in treating various conditions that are currently underserved by existing pharmaceutical solutions. Petri Bio has also been involved in the development of treatments related to COVID-19, using their platform to identify compounds that could potentially neutralize the virus. Their work has garnered attention and interest from major pharmaceutical companies, and they continue to expand their pipeline to include other critical areas of healthcare.

Philips Ventures is the venture capital arm of Royal Philips, focusing on early- to growth-stage investments in healthcare technology startups that align with Philips’ mission to improve patient outcomes, reduce healthcare costs, and transform the healthcare experience. Established in 1998 and based in Amsterdam, Philips Ventures invests globally, supporting companies that develop digital health solutions, medical devices, and health technology services. The fund is business-agnostic but emphasizes sectors like digital software, AI-driven health solutions, and technology-enabled services. Philips Ventures provides not just capital but also strategic support, offering startups access to Philips' extensive clinical and regulatory expertise, global market insights, and deep relationships within the healthcare industry. Their investment strategy includes leading or co-leading rounds, with initial investments typically ranging from $2 million to $5 million, and they actively syndicate deals to collaborate with other investors. Philips Ventures also fosters partnerships between their portfolio companies and Philips' various business units, helping startups scale and navigate the complex healthcare landscape. This approach has led to investments in companies like Elucid, Validic, and MIVI Neuroscience, all of which are pushing the boundaries of healthcare innovation.

Phoenix Venture Partners (PVP), established in 2010 and headquartered in San Mateo, California, is a venture capital firm that specializes in investing in early-stage startups with breakthrough materials science innovations. The firm focuses on sectors such as advanced materials, photonics, electronics, and clean technology. Their investment strategy encompasses seed, venture, and growth stages, providing both capital and strategic guidance to drive the commercialization and scalability of innovative technologies​. PVP has a robust portfolio, including companies like Inkbit, which develops advanced additive manufacturing systems, and FIGUR8, which creates wearable musculoskeletal technology. Other notable investments include Agrology, a company in the agriculture biotechnology space, and Ubicept, specializing in computer vision and image recognition​. The firm is led by experienced professionals such as Dr. Frank Levinson, a co-founder and Managing General Partner, who has a strong track record in building advanced materials companies and was the founder of Finisar Corporation. PVP's recent investments highlight their commitment to transformative technologies, with a focus on sectors that have substantial growth potential and societal impact.

USA, the UK, and Russia. The firm specializes in early-stage investments, focusing on high-tech sectors such as AI, mobility, energy, biotech, and space technology. Phystech Ventures supports startups that leverage scientific advancements to create disruptive solutions and transform industries. The firm's portfolio includes investments in various industries like the internet of things, connected platforms, automotive, education technology, cybersecurity, sensors, robotics, and energy tech. Notable investments include companies such as Osome, H2Drone, Geosteering Technologies, and Coda Devices​​. Phystech Ventures is driven by a team of experienced professionals, including Daniel Shaposhnikov, who leads AI/ML, energy, and mobility verticals, and Ivan Protopopov, who oversees life sciences and space tech investments​.

Picus Capital, founded in 2015 and headquartered in Munich, Germany, is an early-stage venture capital firm with a long-term investment philosophy. The firm focuses on technology-driven sectors such as financial services, HR, energy & climate, healthcare, logistics & mobility, real estate & construction, crypto & web3, deep tech, and e-commerce. Picus Capital has made significant investments in companies like Ledge, Spot My Energy, Cove Living, Poolit, and Alasco, among others. Their portfolio spans across 20+ countries with a diverse range of startups that are innovating in their respective fields. The firm's unique approach emphasizes close partnerships with their portfolio companies, assisting them with strategic decisions and operational challenges. With offices in Munich, London, New York, Beijing, and other key locations, Picus Capital is well-positioned to support global growth and expansion. The firm is led by co-founders Robin Godenrath, Alexander Samwer, and Jeremias Heinrich, who bring extensive experience and a strong entrepreneurial mindset to the table. Their team is dedicated to helping daring technology companies build successful, global enterprises that challenge the status quo and shape the future​

Pillar VC is a venture capital firm based in Boston, Massachusetts, specializing in early-stage investments, particularly in pre-seed and seed rounds. Founded in 2016, the firm focuses on supporting founders from the very beginning, often before formal incorporation, and invests in various sectors including AI/ML, biotech, consumer, enterprise, fintech, and crypto/web3. Pillar VC manages multiple funds, including the recent $192 million raised for Pillar III and Pillar Select. This allows them to continue backing companies with significant potential to become foundational pillars of their industries. Their investment strategy includes leading seed rounds with investments ranging from $2 million to $6 million and making pre-seed investments between $50,000 and $500,000. The firm is distinguished by its commitment to buying common stock to align closely with the founders' interests. Pillar VC also provides robust support through a dedicated platform team that assists with talent acquisition, expert connections, pitch polishing, and investor introductions. This approach has helped foster successful companies like Algorand, Desktop Metal, and PillPack​.

Pioneer Fund, founded in 2018, is a venture capital firm driven by over 400 Y Combinator alumni, targeting early-stage investments in startups emerging from the Y Combinator accelerator. The fund focuses primarily on seed rounds and is industry-agnostic, backing companies across sectors like AI, fintech, life sciences, and consumer products. Notably, Pioneer Fund has supported the rise of Anthropic, an AI startup that became a unicorn in 2023. Geographically, Pioneer Fund predominantly invests in the US, but has also expanded its portfolio with startups from India, Nigeria, and several other countries. The firm tends to co-invest with other prominent players, often alongside Y Combinator itself, as well as other top-tier VCs. Their strategy revolves around writing early checks and providing more than just capital—leveraging the collective expertise of their vast alumni network to offer founders mentorship, connections, and operational insights. Pioneer Fund typically doesn't lead rounds but is quick to follow other strong investors within the YC ecosystem. The fund is managed by a large team of partners and venture partners based in locations like San Francisco, Toronto, and Vancouver. If you’re a YC startup with a strong product-market fit and a clear path to growth, Pioneer Fund might be a key player in your next funding round, especially if you seek connections within the YC network.

Pioneer Fund, founded in 2017, is a venture capital firm based in San Francisco, CA, and Toronto, Canada. This unique fund is driven by over 400 Y Combinator alumni, focusing on investing in top startups that emerge from the Y Combinator accelerator. With a strong emphasis on early-stage investments, Pioneer Fund supports a diverse range of industries, including consumer products, financial services, AI, life sciences, and education technology. Notable investments by Pioneer Fund include companies like Aspire, C16 Biosciences, Curebase, Dover, and OnDeck, reflecting their broad and impactful portfolio. The fund has made over 600 investments and continues to actively support new ventures, emphasizing their commitment to fostering innovation and growth in the startup ecosystem. Pioneer Fund operates with a flexible and founder-friendly approach, often providing quick investment decisions. They also maintain a global investment perspective, with a presence in countries such as India, Nigeria, Argentina, and Chile. This geographical diversity enables them to back startups with international ambitions and scalability. The team at Pioneer Fund is led by founder Daniel Gross, along with other notable members such as Tim Suzman and Rajiv Bhat. They bring a wealth of experience and connections, leveraging their backgrounds as Y Combinator alumni to provide valuable mentorship and support to portfolio companies.

Pipeline Capital is a seed-stage venture capital firm based in Menlo Park, California. Founded in 2014, the firm focuses on investing in innovative business models within both enterprise and consumer technology sectors. Notable investments include Hippo Insurance and Webflow, which highlight their interest in disruptive companies with significant market potential. Their portfolio showcases a variety of industries, with a particular emphasis on enterprise applications and infrastructure. Recent investments include companies like Haul in the consumer sector and Five Sigma Labs in InsurTech, demonstrating their broad investment scope​. Pipeline Capital's strategy revolves around providing not just capital but also mentorship and extensive support to help startups achieve their full potential. They are highly involved with their portfolio companies, offering guidance and leveraging their networks to drive growth and success. The firm has a history of successful exits, including the acquisition of Spiff by Salesforce and the IPO of Hippo Insurance on the NYSE. This track record underscores their ability to identify and nurture high-potential startups from early stages to successful exits.

Pitango Venture Capital, established in 1993 and based in Herzliya, Israel, is one of the largest and most prominent venture capital firms in Israel, managing over $3 billion across various funds. The firm focuses on investing in early-stage startups through Pitango First, growth-stage companies through Pitango Growth, and health tech innovations through Pitango HealthTech. Pitango has backed a range of notable companies that have become leaders in their respective fields. These include Via Transportation, which has revolutionized urban mobility, Taboola, a significant player in content recommendation and discovery, and Varonis Systems, a cybersecurity company. The firm has also been involved in successful exits, such as the acquisition of Anobit by Apple and the IPO of Radware on NASDAQ. The investment strategy of Pitango emphasizes partnering with visionary entrepreneurs and providing them with the necessary resources and guidance to scale their businesses. The team at Pitango includes experienced professionals like Nechemia (Chemi) Peres and Rami Kalish, who bring a wealth of expertise to the firm’s diverse investment portfolio. Pitango's approach is characterized by a strong commitment to innovation and sustainability, ensuring that the companies they invest in are not only successful but also contribute positively to the broader community. This dedication has positioned Pitango as a key player in both the Israeli and global venture capital ecosystems.

Piva Capital is a San Francisco-based venture capital firm, launched in 2019, that targets transformative companies at the intersection of energy, mobility, advanced manufacturing, and new materials. They focus on early to growth-stage startups with breakthrough technologies that address pressing global challenges. Piva backs innovators in fields such as decarbonization, industrial automation, and sustainable production, seeking companies with scalable, cross-industry applications. Some of their notable investments include Boston Metal (decarbonizing steel), Velo3D (revolutionizing additive manufacturing), and Koloma (geologic hydrogen production). Piva’s portfolio is heavily concentrated in North America and Europe, where they partner with visionary entrepreneurs to advance impactful industrial solutions. Piva typically writes large checks, leading rounds and bringing a deep network of industry contacts to help their portfolio companies scale quickly. They are also known for their ESG (Environmental, Social, and Governance) initiatives, embedding sustainability into their investment strategy. The leadership team includes experts like CEO Ricardo Angel and Managing Partner Mark Gudiksen, both based in San Francisco, who bring decades of experience in energy, materials, and industrial sectors​.

Pivotal Ventures, founded by Melinda French Gates in 2015, is a mission-driven investment and incubation company focused on accelerating social progress by addressing systemic barriers, particularly those affecting women and marginalized groups. Unlike traditional VC firms, Pivotal Ventures operates at the intersection of venture capital and philanthropy, deploying a range of funding strategies, including venture investments, grants, and advocacy, to drive impact. The firm primarily targets industries that are crucial for societal progress, such as caregiving, women's health, and technology innovation. Notable investments include companies like CareAcademy, which focuses on training caregivers, and partnerships with funds like Impact America Fund and Rethink Impact, both of which are led by women and emphasize diversity in their investment strategies. Pivotal Ventures is committed to redefining the venture capital landscape by prioritizing diversity and inclusion in both their investment decisions and the teams they support. They are known for investing in early-stage companies and funds that often get overlooked by traditional VCs due to their focus on diverse founders and social impact. Led by Melinda French Gates, with a team including key figures like Erin Harkless Moore, Pivotal Ventures pushes for a more inclusive venture ecosystem, emphasizing that investments with a diversity-first approach are not only socially beneficial but also financially rewarding. The firm’s approach has inspired broader changes in how VC firms evaluate opportunities and support diverse entrepreneurs.

PJC, founded in 2001 and based in Boston, Massachusetts, is an early-stage venture capital firm. PJC focuses on investing in innovative startups across various industries, particularly in AI, consumer technology, health tech, and enterprise software. The firm has made over 129 investments and has achieved several successful exits. Notable investments in PJC's portfolio include Expensify, a leading expense management platform; Nest, a consumer IoT company acquired by Google; and Eden Health, a primary care and insurance navigation service acquired by Centivo. Other significant investments are Neurable, a consumer AI-enabled virtual reality platform, and Openly, a next-generation insurance company. PJC is known for its hands-on approach, providing strategic support and mentorship to help startups scale and achieve market success. The firm emphasizes building long-term relationships with entrepreneurs, supporting them through various stages of growth and development.

Planeteer Capital is a venture capital firm based in New York City that focuses on pre-seed and seed-stage investments in climate tech startups. Founded by Sophie Purdom, a co-founder of Climate Tech VC (CTVC), Planeteer Capital aims to partner with founders who are addressing the challenges of climate change through innovative technologies and solutions. The firm is anchored by an Ivy League endowment and backed by notable investors including Collaborative Fund and former Meta CTO Mike Schroepfer. Planeteer Capital targets sectors such as carbon management, industrial decarbonization, the built environment, climate intelligence and insurance, and sustainable agriculture. The firm’s mission is to empower visionary founders with the necessary capital and network to prove and scale their transformative models. Planeteer Capital distinguishes itself by providing not just financial support, but also strategic guidance and a sophisticated understanding of the climate tech capital stack​​.

Playground Global is an early-stage venture capital firm based in Palo Alto, California, specializing in deep-tech investments. Founded in 2015 by Andy Rubin, Peter Barrett, Matt Hershenson, and Bruce Leak, the firm focuses on transformative technologies that promise to define new industry standards and create entirely new markets. Playground Global's investment strategy targets Seed and Series A companies, with initial investments ranging from $1 million to $20 million. Their portfolio includes companies in next-gen computing, logistics, automation, infrastructure, decarbonization, and engineered biology. The firm recently closed its third fund with $410 million in new capital, bringing its total assets under management to over $1.2 billion. This fund continues Playground's commitment to investing in ambitious founders and groundbreaking technologies. Some notable investments from Fund III include d-Matrix, Ideon Technologies, Amber Bio, Infinimmune, and Atomic AI​. Playground Global supports its portfolio companies not just with capital but also with deep technical and operational expertise. The team, comprising over 40 members, includes many with strong technical backgrounds, ensuring comprehensive support in areas such as engineering, product development, business development, and marketing.

Plexo Capital is a venture capital firm founded in 2018 by Lo Toney, a former partner at Google Ventures (GV). The firm operates on a unique hybrid model, investing both in emerging venture capital funds and directly in early-stage startups, particularly those led by women and people of color. This strategy allows Plexo to tap into a broader and more diverse deal flow, aiming to generate superior returns while increasing diversity within the venture ecosystem. Plexo Capital manages a $42.5 million fund, with investments from prominent backers like Alphabet, Intel Capital, Cisco Investments, and the Ford Foundation. The firm typically invests $500,000 to $5 million in venture funds and $500,000 to $2 million directly in startups. Some of the notable companies in their portfolio include Blavity, PlayVS, and Wrapbook, a payroll management software company that has since become a unicorn. Plexo’s approach is deeply rooted in the belief that diverse perspectives lead to better investment outcomes, particularly at the seed stage where non-traditional networks can provide unique insights. The firm also emphasizes supporting its portfolio companies by leveraging its extensive network of strategic partners and experts in growth, product development, and customer acquisition. Plexo Capital is based in San Francisco but operates globally, with investments spanning across North America, Africa, and Latin America

PLG Ventures is an early-stage venture capital firm based in Santa Monica, California, specializing in providing pre-seed and seed capital to technology-enabled startups. Founded in 2015 by Peter Goldberg, the firm focuses on sectors such as software, SaaS, consumer products, and fintech. Some of their notable investments include AvantStay, an online booking platform for vacation rentals; Hum Capital, a fundraising platform for startups; and Measurabl, which offers SaaS-driven sustainability data collection for buildings. PLG Ventures is known for its hands-on approach, helping founding teams develop leadership skills and company culture while ensuring strong foundations for growth. PLG Ventures aims to support startups by offering a combination of capital, guidance, and strategic resources to help them scale and succeed in competitive markets​.

Plug and Play Tech Center, headquartered in Sunnyvale, California, is the world’s largest startup accelerator and a leading venture capital firm. Known for its expansive global reach, Plug and Play operates in over 50 locations across five continents. Their notable investments include industry giants like PayPal, Dropbox, and LendingClub, along with a portfolio boasting more than 30 unicorns such as Honey and Guardant Health. Focusing on diverse industries such as fintech, health, insurtech, and supply chain, Plug and Play leverages its robust corporate network of 450 partners to drive innovation. Their investment strategy is characterized by small, pre-seed and seed-stage checks typically ranging from $100,000 to $150,000. They maintain an active presence globally, investing equally in U.S.-based and international startups. The firm's founder and CEO, Saeed Amidi, emphasizes high energy and a global approach to foster entrepreneurship. Key team members like George Damouny play vital roles in maintaining Plug and Play’s status as one of the most active investors worldwide. Plug and Play’s investment approach is unique, often engaging startups through their acceleration programs without necessarily investing in every participant. They focus on building ecosystems around each industry to maximize startup potential. Recently, the firm has made 102 investments in Q1 2023 alone, underscoring its dynamic and proactive investment strategy.

Plum Alley is a New York-based venture capital firm founded in 2012 by Deborah Jackson and Andrea Moffitt. The firm focuses on investing in early-stage, high-growth technology and healthcare companies, particularly those with at least one female founder from the STEM fields. Their portfolio includes companies like AiFi, which specializes in autonomous checkout technology, and Gameto, a biotechnology company addressing ovarian aging. Plum Alley has a strong emphasis on supporting companies that tackle significant human and environmental challenges using advanced technology. They have invested nearly $80 million across 32 companies through member investors and their Venture Fund I. Their investment strategy includes offering membership opportunities for investors to engage with curated investment opportunities and targeted venture funds focused on specific sectors​​. The firm has made notable exits, including companies like Shine, Node, and Tinkergarten. They also have a robust portfolio of ongoing investments in sectors such as digital health, smart hardware, and automation.

oint72 Ventures is a global venture capital firm founded by Steven A. Cohen in 2016. Based in New York, Seattle, and San Francisco, Point72 Ventures focuses on fintech, artificial intelligence, and enterprise technology sectors. The firm leverages Point72 Ventures is a global venture capital firm founded by Steven A. Cohen in 2016. Based in New York, Seattle, and San Francisco, Point72 Ventures focuses on fintech, artificial intelligence, and enterprise technology sectors. The firm's investment strategy involves thorough research and a deep understanding of industries. Point72 Ventures writes checks from $250k to $50 million, from pre-seed to pre-IPO rounds. They often lead investment rounds and take board seats to support their portfolio companies. Point72 Ventures has a diverse portfolio including Apex, Tektonic AI, and DriveWealth. The team includes experts like Adam Carson, focusing on fintech and crypto, and Pete Casella, a senior advisor with a strong fintech background. Point72 Ventures engages with passionate founders who are deeply knowledgeable about their industries, emphasizing data and thorough analysis in their investment process. They seek companies with clear potential for innovation and growth.

Polaris Partners, a venture capital firm established in 1996 and headquartered in Boston, Massachusetts, has a distinguished history of investing in transformative healthcare and biotechnology companies. With over 400 companies funded, more than 100 exits, and 50 IPOs, Polaris Partners has solidified its position as a leading investor in the industry​​. The firm's portfolio is diverse, including notable companies such as Ironwood Pharmaceuticals, JibJab Media, LegalZoom, and Living Proof. Polaris Partners focuses primarily on healthcare, life sciences, and biotechnology sectors, targeting innovative care delivery models, digital health solutions, patient and provider platforms, and data science and analytics​ ​. Polaris Partners operates multiple funds, including the Polaris Growth Fund, which supports the expansion of profitable, founder-owned technology companies, and the Polaris Innovation Fund, aimed at accelerating the commercial and therapeutic potential of early-stage academic research​​. Key team members include Brian Chee, Bryce Youngren, and Alexandra Cantley, who bring extensive expertise and leadership to the firm's investment strategies. Polaris Partners prides itself on being more than just investors—they are builders and connectors with a deep network of syndicate partners, universities, and research institutions​​. For entrepreneurs, Polaris Partners offers robust support, leveraging their decades of experience and comprehensive network to help companies achieve successful outcomes and bring innovative therapies to market.

Polychain Capital, founded in 2016 by Olaf Carlson-Wee, is a prominent venture capital firm based in San Francisco that focuses on investments in cryptocurrency and blockchain technology. The firm has established itself as a leader in the digital asset space, managing a diverse portfolio that includes early-stage ventures and later-stage companies. Polychain Capital has made over 260 investments, with notable exits such as Coinbase, Kik, and Compound. Their investment strategy emphasizes supporting transformative blockchain projects and innovative financial technologies. Recent investments include companies like Particle Network and Riema Labs, highlighting their ongoing commitment to advancing blockchain infrastructure and applications. The firm recently raised $200 million for its fourth crypto venture capital fund, underscoring its significant influence and resources in the industry. Polychain Capital's portfolio is broad, encompassing various sectors within the blockchain ecosystem, from decentralized finance (DeFi) platforms to digital asset management tools. Polychain Capital's approach is characterized by a strong focus on identifying and nurturing high-potential projects that leverage blockchain technology to create scalable and impactful solutions. The firm benefits from a deep network of co-investors, including Coinbase Ventures and Hack VC, which further enhances its ability to support and grow its portfolio companies.

Polytech Ventures is a venture capital firm based in Switzerland, focusing on early-stage investments with a strong international outlook. The firm primarily invests in sectors like fintech, insurtech, healthtech, and proptech. Established in 2015, Polytech Ventures has offices in Lausanne, Switzerland, at the EPFL campus, and in San Francisco, USA, providing a bridge for European startups to access the Silicon Valley ecosystem. Polytech Ventures operates under the umbrella of Polytech Ecosystem Ventures, which combines the strengths of Swiss and European technological innovation with the market access and growth opportunities available in the United States. The firm has a $40 million fund aimed at supporting digital transformation across various industries, including fintech, insurtech, digital health, and retail tech. The fund's strategy involves identifying high-potential startups in Switzerland and Europe and helping them establish a presence in the US to accelerate their growth. Notable portfolio companies include Beekeeper, Saphetor, Inpher, BlueFox, and Weft. Polytech Ventures is committed to fostering innovation by providing both capital and strategic guidance to early-stage companies.

Pontifax Venture Capital is a healthcare-focused venture capital firm based in Herzliya, Israel, founded in 2004. The firm manages approximately $1.2 billion across multiple funds and focuses on identifying and investing in transformative life sciences technologies at all stages of development. Pontifax's portfolio includes around 100 companies that address significant unmet medical needs through groundbreaking innovations​. The firm was co-founded by Eli Hurvitz, a legendary figure in the pharmaceutical industry and former CEO of Teva Pharmaceuticals, alongside Ran Nussbaum and Tomer Kariv. Pontifax takes a hands-on approach with its portfolio companies, providing strategic guidance and leveraging extensive networks to help these companies grow and succeed. Pontifax's investment strategy spans various sectors within the life sciences, including biopharmaceuticals, medical devices, and gene therapy. Notable investments include Kite Pharma, which was acquired by Gilead Sciences, and Eloxx Pharmaceuticals, which focuses on treatments for genetic diseases caused by nonsense mutations.